Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergism Through WEE1 and CHK1 Inhibition in Acute Lymphoblastic Leukemia
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 11, Pages 1654
Publisher
MDPI AG
Online
2019-10-25
DOI
10.3390/cancers11111654
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mechanistic Distinctions between CHK1 and WEE1 Inhibition Guide the Scheduling of Triple Therapy with Gemcitabine
- (2018) Siang-Boon Koh et al. CANCER RESEARCH
- Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia
- (2018) Andrea Ghelli Luserna Di Rorà et al. Journal of Hematology & Oncology
- The DNA damage response pathway in normal hematopoiesis and malignancies
- (2017) Domenico Delia et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Replication Catastrophe: When a Checkpoint Fails because of Exhaustion
- (2017) Luis Toledo et al. MOLECULAR CELL
- Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
- (2017) et al. MOLECULES
- The Intra-S Checkpoint Responses to DNA Damage
- (2017) Divya Iyer et al. Genes
- Targeting the ATR-CHK1 Axis in Cancer Therapy
- (2017) Stuart Rundle et al. Cancers
- Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation
- (2016) Valentina Restelli et al. BRITISH JOURNAL OF HAEMATOLOGY
- Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage
- (2016) Ansar Karimian et al. DNA REPAIR
- Cell cycle checkpoint in cancer: a therapeutically targetable double-edged sword
- (2016) Roberta Visconti et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy
- (2016) Rohith Srivas et al. MOLECULAR CELL
- Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia
- (2016) Andrea Ghelli Luserna Di Rorà et al. Oncotarget
- Combined inhibition of Wee1 and Chk1 gives synergistic DNA damage in S-phase due to distinct regulation of CDK activity and CDC45 loading
- (2016) Sissel Hauge et al. Oncotarget
- Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities
- (2016) Kumar Sanjiv et al. Cell Reports
- Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma
- (2015) Gry Irene Magnussen et al. BMC CANCER
- In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia
- (2015) Ilaria Iacobucci et al. Journal of Hematology & Oncology
- LY2606368 Causes Replication Catastrophe and Antitumor Effects through CHK1-Dependent Mechanisms
- (2015) C. King et al. MOLECULAR CANCER THERAPEUTICS
- Wee1 is required to sustain ATR/Chk1 signaling upon replicative stress
- (2015) Priyanka Saini et al. Oncotarget
- Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
- (2015) Rosaria Chilà et al. Oncotarget
- TP53 mutations occur in 15.7% of ALL and are associated with MYC-rearrangement, low hypodiploidy, and a poor prognosis
- (2014) A. Stengel et al. BLOOD
- Acute lymphoblastic leukemia with low hypodiploid/near triploid karyotype is a specific clinical entity and exhibits a very highTP53mutation frequency of 93%
- (2014) Verena Mühlbacher et al. GENES CHROMOSOMES & CANCER
- Genotoxic Anti-Cancer Agents and Their Relationship to DNA Damage, Mitosis, and Checkpoint Adaptation in Proliferating Cancer Cells
- (2014) Lucy Swift et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
- (2014) Wenxiu Qi et al. Journal of Hematology & Oncology
- Cdks, cyclins and CKIs: roles beyond cell cycle regulation
- (2013) S. Lim et al. DEVELOPMENT
- CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo
- (2013) L. Chaudhuri et al. HAEMATOLOGICA
- The Role of Cdc25A in the Regulation of Cell Proliferation and Apoptosis
- (2012) Tao Shen et al. Anti-Cancer Agents in Medicinal Chemistry
- Unique functions of CHK1 and WEE1 underlie synergistic anti-tumor activity upon pharmacologic inhibition
- (2012) Amy D Guertin et al. Cancer Cell International
- Combination Therapy Targeting the Chk1 and Wee1 Kinases Shows Therapeutic Efficacy in Neuroblastoma
- (2012) M. R. Russell et al. CANCER RESEARCH
- Combined inhibition of Chk1 and Wee1: In vitro synergistic effect translates to tumor growth inhibition in vivo
- (2012) Laura Carrassa et al. CELL CYCLE
- Claspin and Chk1 regulate replication fork stability by different mechanisms
- (2011) Jennifer Scorah et al. CELL CYCLE
- Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease
- (2011) Raquel Domínguez-Kelly et al. JOURNAL OF CELL BIOLOGY
- Mutations and Deletions of the TP53 Gene Predict Nonresponse to Treatment and Poor Outcome in First Relapse of Childhood Acute Lymphoblastic Leukemia
- (2011) Jana Hof et al. JOURNAL OF CLINICAL ONCOLOGY
- Safeguarding genome integrity: the checkpoint kinases ATR, CHK1 and WEE1 restrain CDK activity during normal DNA replication
- (2011) C. S. Sorensen et al. NUCLEIC ACIDS RESEARCH
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Regulation of the DNA Damage Response to DSBs by Post-Translational Modifications
- (2010) C. Oberle et al. CURRENT GENOMICS
- Dual Regulation of Cdc25A by Chk1 and p53-ATF3 in DNA Replication Checkpoint Control
- (2008) Anastasia R. Demidova et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cellular commitment to reentry into the cell cycle after stalled DNA is determined by site-specific phosphorylation of Chk1 and PTEN
- (2008) S. A. Martin et al. MOLECULAR CANCER THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started